NEW HAVEN, Conn., March 1, 2018 /PRNewswire/ — Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) (“Biohaven” or the “Company”) announced positive results today from its bioequivalence study with rimegepant Zydis® orally dissolving tablets (ODT). Rimegepant is a small molecule,…
The World's #1 Mining Property Marketplace
Established 2009 — Connecting Buyers and Sellers Worldwide
